Old Web
English
Sign In
Acemap
>
authorDetail
>
Sascha Keller
Sascha Keller
Boehringer Ingelheim
Medicine
Pharmacology
Pharmacokinetics
Cmax
Glycine transporter 1
5
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The association between plasma tryptophan catabolites and depression: The role of symptom profiles and inflammation.
2021
Brain Behavior and Immunity
Yuri Milaneschi
Kelly A. Allers
Aartjan T. F. Beekman
Erik J. Giltay
Sascha Keller
Robert A. Schoevers
Sigurd D. Süssmuth
Heiko G. Niessen
Brenda W. J. H. Penninx
Show All
Source
Cite
Save
Citations (1)
Effects of Cytochrome P450 3A4 Induction and Inhibition on the Pharmacokinetics of BI 425809, a Novel Glycine Transporter 1 Inhibitor.
2021
European Journal of Drug Metabolism and Pharmacokinetics
Michael Desch
Glen Wunderlich
Markus Goettel
Sophia Goetz
Karl-Heinz Liesenfeld
Tom S. Chan
Holger Rosenbrock
Regina Sennewald
Jasmin Link
Sascha Keller
Sven Wind
Show All
Source
Cite
Save
Citations (0)
Exosomal miRNAs as Potential Biomarkers to Monitor Phosphodiesterase 5 Inhibitor Induced Anti-Fibrotic Effects on CCl4 Treated Rats.
2020
International Journal of Molecular Sciences
Andre Broermann
Ramona Schmid
Ogsen Gabrielyan
Marlene Sakowski
Claudia Eisele
Sascha Keller
Michael Wolff
Patrick Baum
Birgit Stierstorfer
Jochen Huber
Bernhard K. Krämer
Berthold Hocher
Ruediger Streicher
Denis Delic
Show All
Source
Cite
Save
Citations (4)
Evaluation of Pharmacokinetics and Pharmacodynamics of BI 425809, a Novel GlyT1 Inhibitor: Translational Studies
2018
Clinical and Translational Science
Holger Rosenbrock
Michael Desch
Oliver Kleiner
Cornelia Dorner-Ciossek
Bernhard Schmid
Sascha Keller
Christina Schlecker
Viktoria Moschetti
Sophia Goetz
Karl-Heinz Liesenfeld
Gwenaëlle Fillon
Riccardo Giovannini
Steven Ramael
Glen Wunderlich
Sven Wind
Show All
Source
Cite
Save
Citations (8)
PK/PD properties of BI 836880, a vascular endothelial growth factor (VEGF)/angiopoietin-2 (Ang-2)-blocking nanobody, in patients (pts) with advanced/metastatic solid tumors.
2018
Journal of Clinical Oncology
Christophe Le Tourneau
Josep Tabernero
Rainer Claus
Ralph Fritsch
Francesco Ricci
Elena Elez
Björn Hackanson
Ulrich Kunz
Thomas Arnhold
Heiko G. Niessen
Sascha Keller
Ralph Graeser
Nicolas Isambert
Show All
Source
Cite
Save
Citations (1)
1